Target intelligence / Profile preview

Tubulin alpha-3C chain (TUBA3C)

Target
TUBA3C
Molecular classification
Cytoskeletal protein, Structural protein, Tubulin family
01

Overview

Tubulin alpha-3C chain (TUBA3C) is a major structural protein of microtubules, essential cytoskeletal filaments in eukaryotic cells. Microtubules are involved in cell division, intracellular transport, and maintaining cell shape. TUBA3C represents an alpha-tubulin isotype and forms heterodimers with beta-tubulin to build microtubules. It binds nucleotides (GTP/GDP), exhibits GTPase activity, and is ubiquitously involved in the formation of the cytoskeleton. Genetic variations in TUBA3C are associated with several cancers and rare syndromes. As a member of the tubulin family, it is targeted by various antimitotic drugs commonly used in cancer therapy, which disrupt microtubule dynamics to inhibit cell proliferation[1][2][3][8].

Other names
Tubulin alpha-3D chainTubulin alpha-2 chainTubulin alpha-3C/D chainAlpha-tubulin 3CAlpha-tubulin 3DAlpha-tubulin 2TUBA2bA408E5.3Detyrosinated tubulin alpha-3C chain
02

Mechanism of action

Inhibition of microtubule polymerization (vinca alkaloids, colchicine); Stabilization of microtubules (taxanes such as paclitaxel, docetaxel)

03

Biological functions

Structural constituent of cytoskeletonMicrotubule polymerizationCell divisionIntracellular transport
04

Disease associations

Cancer (bladder cancer, lung cancer, ovarian cancer, breast cancer, thyroid cancer, head and neck carcinoma, peritoneal carcinoma, fallopian tube neoplasms)Genetic syndromes (Clouston hidrotic ectodermal dysplasia, Kabuki syndrome, Teebi hypertelorism syndrome)NeutropeniaSchizophrenia
05

Safety considerations

Peripheral neuropathy (due to disruption of microtubule function by drugs)MyelosuppressionDrug resistance (e.g., tubulin mutations can confer resistance to antimicrotubule agents)
06

Interacting drugs

Colchicine

3 more in the full profile.

07

Biomarkers

Expression of tubulin alpha-3C in tumor tissue (potential for use as a biomarker in various cancers; class effect for tubulins, not unique to TUBA3C)

Beyond the preview

Go deeper on Tubulin alpha-3C chain (TUBA3C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tubulin alpha-3C chain (TUBA3C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call